Regeneron Secures FDA Approval for Hearing Loss Therapy

Regeneron Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its new therapy aimed at treating hearing loss. This marks a significant development in the field of audiology.